BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29922292)

  • 21. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
    Shishido-Hara Y; Higuchi K; Ohara S; Duyckaerts C; Hauw JJ; Uchihara T
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):299-308. PubMed ID: 18379438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assembly of Epstein-Barr Virus Capsid in Promyelocytic Leukemia Nuclear Bodies.
    Wang WH; Kuo CW; Chang LK; Hung CC; Chang TH; Liu ST
    J Virol; 2015 Sep; 89(17):8922-31. PubMed ID: 26085145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PML-RARα stabilized by zinc in human acute promyelocytic leukemia NB4 cells.
    Zhu B; Wang JY; Zhou JJ; Zhou F; Cheng W; Liu YT; Wang J; Chen X; Chen DH; Luo L; Hua ZC
    J Inorg Biochem; 2017 Oct; 175():92-100. PubMed ID: 28743050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum-dependent expression of promyelocytic leukemia protein suppresses propagation of influenza virus.
    Iki S; Yokota S; Okabayashi T; Yokosawa N; Nagata K; Fujii N
    Virology; 2005 Dec; 343(1):106-15. PubMed ID: 16154611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGF-β induces PML SUMOylation, degradation and PML nuclear body disruption.
    El-Asmi F; El-Mchichi B; Maroui MA; Dianoux L; Chelbi-Alix MK
    Cytokine; 2019 Aug; 120():264-272. PubMed ID: 31153006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PML plays both inimical and beneficial roles in HSV-1 replication.
    Xu P; Mallon S; Roizman B
    Proc Natl Acad Sci U S A; 2016 May; 113(21):E3022-8. PubMed ID: 27162364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
    Adamson AL; Kenney S
    J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation.
    Maroui MA; Maarifi G; McManus FP; Lamoliatte F; Thibault P; Chelbi-Alix MK
    Mol Cell Proteomics; 2018 Jun; 17(6):1196-1208. PubMed ID: 29535160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Implication of PML nuclear bodies in intrinsic and innate immunity].
    Maroui MA; El Asmi F; Dutrieux J; Chelbi-Alix MK; Nisole S
    Med Sci (Paris); 2014; 30(8-9):765-71. PubMed ID: 25174753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagic degradation of PML promotes susceptibility to HSV-1 by stress-induced corticosterone.
    Li W; Luo Z; Yan CY; Wang XH; He ZJ; Ouyang SH; Yan C; Liu LF; Zhou QQ; Mu HL; Gong HB; Duan WJ; Liang L; Kurihara H; Feng D; Li YF; He RR
    Theranostics; 2020; 10(20):9032-9049. PubMed ID: 32802177
    [No Abstract]   [Full Text] [Related]  

  • 31. The interferon-induced antiviral protein PML (TRIM19) promotes the restriction and transcriptional silencing of lentiviruses in a context-specific, isoform-specific fashion.
    Masroori N; Merindol N; Berthoux L
    Retrovirology; 2016 Mar; 13():19. PubMed ID: 27000403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interplay between RNA Viruses and Promyelocytic Leukemia Nuclear Bodies.
    Neerukonda SN
    Vet Sci; 2021 Mar; 8(4):. PubMed ID: 33807177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyrrolidine dithiocarbamate inhibits enterovirus 71 replication by down-regulating ubiquitin-proteasome system.
    Lin L; Qin Y; Wu H; Chen Y; Wu S; Si X; Wang H; Wang T; Zhong X; Zhai X; Tong L; Pan B; Zhang F; Zhong Z; Wang Y; Zhao W
    Virus Res; 2015 Jan; 195():207-16. PubMed ID: 25456405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis.
    Too IHK; Bonne I; Tan EL; Chu JJH; Alonso S
    PLoS Pathog; 2018 Jan; 14(1):e1006778. PubMed ID: 29324904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of EV71 3C polymorphisms with clinical severity.
    Ma HY; Lu CY; Tsao KC; Shih HM; Cheng AL; Huang LM; Chang LY
    J Microbiol Immunol Infect; 2018 Oct; 51(5):608-613. PubMed ID: 28711442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir.
    Hung HC; Wang HC; Shih SR; Teng IF; Tseng CP; Hsu JT
    J Infect Dis; 2011 Jun; 203(12):1784-90. PubMed ID: 21536800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EV71 Infection Induces IFNβ Expression in Neural Cells.
    Huang HI; Lin JY; Chen SH
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31817126
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Caine EA; Osorio JE
    J Virol; 2017 Mar; 91(5):. PubMed ID: 27974562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The functional roles of PML nuclear bodies in genome maintenance.
    Chang HR; Munkhjargal A; Kim MJ; Park SY; Jung E; Ryu JH; Yang Y; Lim JS; Kim Y
    Mutat Res; 2018 May; 809():99-107. PubMed ID: 28521962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of promyelocytic leukemia protein in host antiviral defense.
    Geoffroy MC; Chelbi-Alix MK
    J Interferon Cytokine Res; 2011 Jan; 31(1):145-58. PubMed ID: 21198351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.